← European Medicine Shortage Tracker · all medicines

Bupivacaina cloridrato shortage — availability across Europe

Bupivacaina cloridrato currently has availability issues reported in 1 European register: Italy.

MEDICALLY REVIEWED

Dr. Chrysoula I. Liakou MD, PhD

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Shortage ATC — · also listed as: BUPIVACAINA CLORIDRATO · data refreshed 7 August 2026

Key facts

As of 7 August 2026, Bupivacaina cloridrato has active availability issues in 1 of 10 tracked European registers.
Registers reporting issues: Italy.
Longest-running open report: since 2025-01-06 (19 months, Italy).
Data source: 1 official medicines-agency register, refreshed daily.

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Bupivacaina cloridrato, covering 2 affected product presentations. The longest-running open report was filed in Italy on 2025-01-06 and has now been open for about 19 months. Where agencies state a cause, commercial decisions or discontinuation lead with 2 of the 2 stated-cause reports. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇮🇹 Italy	Shortage BUPIVACAINA RECORDATI + 1 more products BUPIVACAINA RECORDATI	2025-01-06	—	Motivi commerciali Alternatives: AIFA: equivalents with the same active substance are available.	register ↗

Full report history (2 register entries)

Every individual register entry for Bupivacaina cloridrato in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇮🇹 IT	BUPIVACAINA RECORDATI	Shortage	2028-04-01	—	Motivi commerciali
🇮🇹 IT	BUPIVACAINA RECORDATI	Shortage	2025-01-06	—	Motivi commerciali

Frequently asked

Is Bupivacaina cloridrato currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

Are there alternatives to Bupivacaina cloridrato?

2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Bupivacaina cloridrato availability data come from?

Directly from the official medicines-agency register that lists Bupivacaina cloridrato: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Bupivacaina cloridrato — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bupivacaina-cloridrato/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Bupivacaina cloridrato availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bupivacaina-cloridrato/">Bupivacaina cloridrato shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Bupivacaina cloridrato: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.